[go: up one dir, main page]

AU2011263533B2 - Method,array and use thereof - Google Patents

Method,array and use thereof Download PDF

Info

Publication number
AU2011263533B2
AU2011263533B2 AU2011263533A AU2011263533A AU2011263533B2 AU 2011263533 B2 AU2011263533 B2 AU 2011263533B2 AU 2011263533 A AU2011263533 A AU 2011263533A AU 2011263533 A AU2011263533 A AU 2011263533A AU 2011263533 B2 AU2011263533 B2 AU 2011263533B2
Authority
AU
Australia
Prior art keywords
biomarkers
proteome
sample
subject
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011263533A
Other languages
English (en)
Other versions
AU2011263533A1 (en
AU2011263533A8 (en
Inventor
Carl Arne Krister Borrebaeck
Christer Lars Bertil Wingren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Publication of AU2011263533A1 publication Critical patent/AU2011263533A1/en
Publication of AU2011263533A8 publication Critical patent/AU2011263533A8/en
Application granted granted Critical
Publication of AU2011263533B2 publication Critical patent/AU2011263533B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2011263533A 2010-06-11 2011-06-09 Method,array and use thereof Ceased AU2011263533B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1009798.8A GB201009798D0 (en) 2010-06-11 2010-06-11 Method,array and use thereof
GB1009798.8 2010-06-11
PCT/GB2011/000865 WO2011154698A2 (fr) 2010-06-11 2011-06-09 Procédé, groupement, et leur utilisation

Publications (3)

Publication Number Publication Date
AU2011263533A1 AU2011263533A1 (en) 2013-01-10
AU2011263533A8 AU2011263533A8 (en) 2013-03-21
AU2011263533B2 true AU2011263533B2 (en) 2016-11-03

Family

ID=42471508

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011263533A Ceased AU2011263533B2 (en) 2010-06-11 2011-06-09 Method,array and use thereof

Country Status (11)

Country Link
US (2) US20130143760A1 (fr)
EP (1) EP2580592B1 (fr)
JP (1) JP6104796B2 (fr)
CN (1) CN103038642B (fr)
AU (1) AU2011263533B2 (fr)
BR (1) BR112012031444A2 (fr)
CA (1) CA2801863A1 (fr)
ES (1) ES2608956T3 (fr)
GB (1) GB201009798D0 (fr)
IN (1) IN2013CN00297A (fr)
WO (1) WO2011154698A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
US10928402B2 (en) 2012-12-28 2021-02-23 Nx Prenatal Inc. Treatment of spontaneous preterm birth
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
GB2538006A (en) * 2014-05-22 2016-11-02 Scripps Research Inst Gene expression profiles associated with sub-clinical kidney transplant rejection
CA2965408C (fr) * 2014-10-24 2023-10-24 Koninklijke Philips N.V. Pronostic medical et prediction de reponse a un traitement a l'aide de plusieurs activites de voies de signalisation cellulaire
CA2976947C (fr) * 2015-02-18 2023-02-28 Siemens Healthcare Diagnostics Inc. Detection basee sur la localisation de types de fentes de plateau et de types de tubes dans un systeme de vision
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
JP2019505815A (ja) * 2015-12-04 2019-02-28 エヌエックス・プリネイタル・インコーポレイテッドＮＸ Ｐｒｅｎａｔａｌ Ｉｎｃ． 自然早産リスクを層別化するための循環マイクロ粒子の使用
CN109444402B (zh) * 2018-12-18 2021-05-28 郑州安图生物工程股份有限公司 去甲肾上腺素发光免疫检测试剂盒

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169789D1 (en) 1980-05-02 1985-05-15 Edward P Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5376531A (en) 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
WO1997025426A2 (fr) 1996-01-11 1997-07-17 Corixa Corporation Compositions et procedes pour le traitement et le diagnostic du cancer du sein
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
RO114835B1 (ro) 1997-03-17 1999-07-30 Ioan Puşcaş Metodă rapidă de diagnostic al cancerelor
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
AUPP525198A0 (en) 1998-08-13 1998-09-03 Medvet Science Pty. Ltd. Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof
US6492505B1 (en) 1999-02-01 2002-12-10 Incyte Genomics, Inc. Composition for detection of genes encoding membrane-associated proteins
JP2005503779A (ja) 2001-06-10 2005-02-10 アイアールエム，エルエルシー 致死性の高い癌の分子シグネチャー
WO2004037996A2 (fr) 2002-10-24 2004-05-06 Duke University Evaluation des etats relatifs au cancer du sein et des resultats a l'aide de profils d'expression genique
US20040087571A1 (en) 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040259161A1 (en) 2003-03-12 2004-12-23 Fredrik Nilsson Screening assay
CA2527571A1 (fr) 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits et procedes d'identification, d'evaluation et de prevention, et therapie anticancereuse
EP1639090A4 (fr) 2003-06-09 2008-04-16 Univ Michigan Compositions et methodes de traitement et de diagnostic du cancer
JP4711963B2 (ja) * 2003-09-15 2011-06-29 オクラホマ メディカル リサーチ ファウンデーション 炎症性疾患および自己免疫疾患を診断、治療および評価するためにサイトカインアッセイを用いる方法
ES2377407T3 (es) 2003-10-15 2012-03-27 F. Hoffmann-La Roche Ag Utilización de la proteína ASC como marcador para cáncer de seno
WO2005080570A1 (fr) 2004-02-24 2005-09-01 Mitsubishi Rayon Co., Ltd. Gene relatif a l'estimatuon du pronostic postopératoire pour le cancer du poumon
EP1746902A4 (fr) 2004-05-05 2007-06-13 Univ Northeastern Chromatographie d'affinite multi-lectine et ses utilisations
WO2006105642A1 (fr) 2005-04-05 2006-10-12 British Columbia Cancer Agency Marqueurs biologiques pour la detection du cancer du poumon et utilisations de ceux-ci
EP1896855A2 (fr) 2005-06-21 2008-03-12 Jean-Paul Borg Biomarqueurs du cancer du sein
US7972770B2 (en) 2005-08-16 2011-07-05 Memorial Sloan-Kettering Cancer Center Methods of detection of cancer using peptide profiles
EP1777523A1 (fr) 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthode pour pronostiquer la progression d'un cancer et les résultats du patient et les moyens pour performer la méthode
WO2007056011A2 (fr) 2005-11-02 2007-05-18 Bayer Healthcare Llc Methodes pour la prevision et le pronostic du cancer, et pour la surveillance de therapie anticancereuse
JP2009519460A (ja) * 2005-12-16 2009-05-14 エレクトロフォレティックス リミテッド 結腸直腸癌の診断と予後
SG142186A1 (en) 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
AU2008231575A1 (en) 2007-03-27 2008-10-02 Immunovia Ab Protein signature/markers for the detection of adenocarcinoma
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
EP2269070A1 (fr) * 2008-03-14 2011-01-05 DNAR, Inc Protéines de réparation de l'adn associées à des cancers du sein triple négatifs et leurs procédés d'utilisation
EP2105740A1 (fr) * 2008-03-28 2009-09-30 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. Biomarqueurs pour surveiller ou prédire le traitement du cancer
US8519116B2 (en) 2008-04-29 2013-08-27 Siemens Healthcare Diagnostics Inc. Method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
JP2010151800A (ja) 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (fr) 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prédiction de la réponse à une chimiothérapie à base de taxane/d'anthracycline lors d'un cancer du sein
US8597885B2 (en) 2009-01-28 2013-12-03 University Of Notre Dame Accelerated progression relapse test
AU2010321829B2 (en) 2009-11-23 2015-07-30 Genomic Health, Inc. Methods to predict clinical outcome of cancer
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
GB201410226D0 (en) 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CARLSSON, A. et al. European Journal of Cancer, 2008, Vol. 44, pages 472-480 *

Also Published As

Publication number Publication date
CN103038642B (zh) 2017-02-22
CA2801863A1 (fr) 2011-12-15
GB201009798D0 (en) 2010-07-21
AU2011263533A1 (en) 2013-01-10
US20180313852A1 (en) 2018-11-01
WO2011154698A3 (fr) 2012-03-01
JP2013529773A (ja) 2013-07-22
WO2011154698A8 (fr) 2013-01-17
BR112012031444A2 (pt) 2016-10-25
AU2011263533A8 (en) 2013-03-21
EP2580592A2 (fr) 2013-04-17
EP2580592B1 (fr) 2016-10-05
IN2013CN00297A (fr) 2015-07-03
US10564163B2 (en) 2020-02-18
WO2011154698A2 (fr) 2011-12-15
CN103038642A (zh) 2013-04-10
ES2608956T3 (es) 2017-04-17
JP6104796B2 (ja) 2017-03-29
US20130143760A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
US10564163B2 (en) Method, array and use thereof
US20200088742A1 (en) Method, array and use for determining the presence of pancreatic cancer
JP6465902B2 (ja) 腺癌の検出のための蛋白質シグネチャー／マーカー
US20190128891A1 (en) Method, array and use thereof
US20100304979A1 (en) Diagnostic Methods and Arrays for Use in the Same
AU2014247083B2 (en) Methods and arrays for use in biomarker detection for prostate cancer

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 27 , NO 1 , PAGE(S) 129 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME IMMUNOVIA AB, APPLICATION NO. 2011263533, UNDER INID (72) CORRECT THE CO-INVENTOR TO BORREBAECK, CARL ARNE KRISTER

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired